Diagonal Bio AB (publ) (DIABIO.ST)

SEK 0.02

(4.18%)

Eps Summary of Diagonal Bio AB (publ)

  • Diagonal Bio AB (publ)'s latest annual eps in 2023 was -0.32 SEK , up 81.18% from previous year.
  • Diagonal Bio AB (publ)'s latest quarterly eps in 2024 Q3 was -0.00 SEK , up 74.8% from previous quarter.
  • Diagonal Bio AB (publ) reported an annual eps of -1.70 SEK in 2022, down -70.0% from previous year.
  • Diagonal Bio AB (publ) reported an annual eps of -1.70 SEK in 2021, down -488.24% from previous year.
  • Diagonal Bio AB (publ) reported a quarterly eps of -0.00 SEK for 2024 Q3, up 74.8% from previous quarter.
  • Diagonal Bio AB (publ) reported a quarterly eps of -0.07 SEK for 2024 Q1, down -17.06% from previous quarter.

Annual Eps Chart of Diagonal Bio AB (publ) (2023 - 2020)

Historical Annual Eps of Diagonal Bio AB (publ) (2023 - 2020)

Year Eps Eps Growth
2023 -0.32 SEK 81.18%
2022 -1.70 SEK -70.0%
2021 -1.70 SEK -488.24%
2020 -0.17 SEK 0.0%

Peer Eps Comparison of Diagonal Bio AB (publ)

Name Eps Eps Difference
Alligator Bioscience AB (publ) -0.55 SEK 41.818%
Ziccum AB (publ) -1.54 SEK 79.221%
Modus Therapeutics Holding AB (publ) -1.01 SEK 68.317%
BioArctic AB (publ) 2.60 SEK 112.308%
Sprint Bioscience AB (publ) -0.01 SEK -4979.365%
Mendus AB (publ) -4.40 SEK 92.727%
Genovis AB (publ.) 0.94 SEK 134.043%
Intervacc AB (publ) -1.69 SEK 81.065%
QuiaPEG Pharmaceuticals Holding AB (publ) -0.22 SEK -45.455%
Active Biotech AB (publ) -0.17 SEK -88.235%
Magle Chemoswed Holding AB (publ) 1.13 SEK 128.319%
Bio-Works Technologies AB (publ) -1.57 SEK 79.618%
Aptahem AB (publ) -0.05 SEK -562.526%
Vicore Pharma Holding AB (publ) -3.22 SEK 90.062%
Kancera AB (publ) -0.80 SEK 60.0%
Infant Bacterial Therapeutics AB (publ) -9.95 SEK 96.784%
Fluicell AB (publ) -0.24 SEK -33.333%
Saniona AB (publ) -1.29 SEK 75.194%
Lipigon Pharmaceuticals AB (publ) -0.19 SEK -68.421%
Biovica International AB (publ) -2.14 SEK 85.047%
Spago Nanomedical AB (publ) -0.43 SEK 25.581%
AcouSort AB (publ) -1.29 SEK 75.194%
Xintela AB (publ) -0.13 SEK -146.154%
Abliva AB (publ) -0.09 SEK -253.982%
Egetis Therapeutics AB (publ) -1.27 SEK 74.803%
Karolinska Development AB (publ) 0.02 SEK 1700.0%
OncoZenge AB (publ) -1.36 SEK 76.471%
Amniotics AB (publ) -0.01 SEK -2809.091%
2cureX AB (publ) -1.85 SEK 82.703%
CombiGene AB (publ) -1.80 SEK 82.222%
Asarina Pharma AB (publ) -0.57 SEK 43.86%
Calliditas Therapeutics AB (publ) -8.69 SEK 96.318%
Camurus AB (publ) 7.78 SEK 104.113%
Corline Biomedical AB -0.08 SEK -280.048%
IRLAB Therapeutics AB (publ) -3.43 SEK 90.671%
Isofol Medical AB (publ) -0.23 SEK -39.13%
I-Tech AB 1.70 SEK 118.824%
Hansa Biopharma AB (publ) -15.83 SEK 97.979%
Cyxone AB (publ) -0.22 SEK -45.455%
ExpreS2ion Biotech Holding AB (publ) -1.98 SEK 83.838%
Biosergen AB -0.60 SEK 46.667%
Cantargia AB (publ) -1.65 SEK 80.606%
NextCell Pharma AB -1.03 SEK 68.932%
Xspray Pharma AB (publ) -6.76 SEK 95.266%
Elicera Therapeutics AB (publ) -0.83 SEK 61.446%
Nanologica AB (publ) -2.05 SEK 84.39%
SynAct Pharma AB -6.64 SEK 95.181%
Annexin Pharmaceuticals AB (publ) -0.26 SEK -23.077%
Stayble Therapeutics AB (publ) -0.92 SEK 65.217%
LIDDS AB (publ) -0.63 SEK 49.206%
Lipum AB (publ) -4.45 SEK 92.809%
BioInvent International AB (publ) -5.02 SEK 93.625%
Alzinova AB (publ) -0.41 SEK 21.951%
Oncopeptides AB (publ) -1.96 SEK 83.673%
Pila Pharma AB (publ) -0.47 SEK 31.915%
Guard Therapeutics International AB (publ) -11.26 SEK 97.158%
Scandinavian ChemoTech AB (publ) -1.13 SEK 71.681%
Simris Alg AB (publ) -0.16 SEK -100.0%
Diamyd Medical AB (publ) -1.60 SEK 80.0%
Xbrane Biopharma AB (publ) -1.27 SEK 74.803%
Ascelia Pharma AB (publ) -3.24 SEK 90.123%